arch27
EN_01270334_1838
Bruce Fenstermacher looks at the bottle of pills that he will take to target a rare mutation in his cancer, in New York, Feb. 8, 2017. Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients. (George Etheredge/The New York Times)
MINIMALNA CENA 100USD!!!
2017-02-08
GEORGE ETHEREDGE/The New York Ti/EAST NEWS
The New York Times Agency
GEORGE ETHEREDGE
h_14994275
3,01MB
28cm x 19cm przy 300dpi
2017, 8, A, AMERICA, AND, AT, BOTTLE, BREAKTHROUGHS, BROUGHT, BRUCE, CANCER, CLINICAL, CRUSH, DEVELOP, DRUG, ETHEREDGE, FEB, FENSTERMACHER, FOR, GEORGE, HAVE, HE, HIS, IMMUNOTHERAPY, IN, LOOKS, MEDICAL, MEDICINE, MUTATION, NATIONAL, NEW, NORTH, OF, PATIENTS, PILLS, PROFITABLE, RARE, RUSH, SCIENCE, SCRAMBLING, TAKE, TARGET, THAT, THE, TIMES, TO, TREATMENTS, TRIAL, TRIALS, WILL, YORK,